Professional Documents
Culture Documents
O exame bem masculino adulto deve incorporar orientaço ã baseada em evidências para a promoço ã de tó ima
saúde e bem-estar, incluindo testes mostrados para melhorar os resultados de saúde de rastreio. u Q ase um terço do
relatório de homens, não tendo um médico da atenço ã primária. A história médica deve incluir o uso da
substância; fatores de risco para sexualmente trans - mitted infecçeõ s; hábitos de dieta e exercício; e os sintomas
da depressão. Exame físico deve incluir a pressão arterial e corpo triagem de n í dice de massa. Homens com
sustentado pressão arterial maior u q e 135/80 mm Hg devem ser selecionados para diabetes mellitus. aR streio de
lipídios é garantida em todos os homens 35 anos e mais velhos, e nos homens 20 a 34 anos de idade u q e têm fatores
de risco cardiovascular. Triagem de ultra-som para aneurisma da aorta abdominal deve ocorrer entre 65 e 75 anos de
idade nos homens u q e nunca fumaram. Há evidências de insufcient para recomendar a triagem de homens para o
câncer de pele ou osteoporose. A força de tarefa de serviços preventivos dos EUA
provisoriamente recomendou contra próstata-específico antígeno-com base de triagem
para câncer de próstata porque os danos de testes e overtreatment são superiores aos
potenciais benefícios. Triagem para câncer colorretal deve começar aos 50 anos de idade
em homens de risco médio e con-continuar até pelo menos 75 anos de idade. aR streio deve
ser realizado por sangue occult fecal alta sensibilidade, testando todos os anos, exible
sig-moidoscopy a cada cinco anos combinada com pesquisa de sangue oculta fecal teste a cada
três anos, ou colonoscopia cada 10 anos. O EUA Preven - tiva Services Task Force recomenda
contra o rastreio para o cancro testicular e doença pulmonar obstrutiva crônica.
Imunizaçeõ s devem ser recomendadas de acordo com as diretrizes do Comitê Consultivo
T
Ver editorial relacionado
²
na página 956.
objetivos do exame bem masculinoentre 15 e 65 anos de idade foram signi -
adulto são fornecer orientaçeõ s cativamente menos provável do que as
Informações do
²
artigo, é fornecido na bidity e mortalidade de doenças crónicas e para fornecer em percentagem do totais
em três homens relatórios não tendo visitas). Quase um
página 972. vacinas e seleçeõ s apropriadas à idade. A principalnenhum fonte médico da atenção primária,
de orientaçeõ s de cuidados preventivos é o EUA Preven em comparaç
5 ão com uma em cinco
- tiva Services Task Force (USPSTF), que mulheres.
Controle e Dados
programa dos decentros
prevençpara doença
ão (CDC)
1 que uma percentagem substancial dos
informa as condiçeõ s clínicas da homens têm subopti-mal estado de saúde,
Academia Americana de méd2 icos de fatores de(Tabela
risco e seguro
1).
6
família. Orientaç
produzido por eõespecialidade
s grupos podem oferecer
orientaço ã addi-cional, mas podem fornecer História
recomendaçeõ s conicting. Atualmente, não há O histórico médico de machos adultos
consenso sobre a frequência ideal de exames bem deverão incluir histórias médicas e
masculinos adultos. cirúrgicas, como bem como o atual uso de
Socialização masculina, juntamente com medicaçoã e alergias. História familiar de
chal-Quisera no acesso aos serviços de saúde, câncer e doenças crônicas deve ser obtida.
problemas de cre-ates signicativa para História social deve centrar-se sobre os riscos
homens em saber quando acessar 3 cuidados do estilo de vida que contribuem para o
preventivos. Em 2007, os homens prematura morbidade e mortalidade, incluindo
Baixado do site da Web de médico de família americano em www.aafp.org/afp. Copyright © 2012 AmericanaAcademy
substânde
ciamédicos de família. Para o privado, Pussy - médico de família americano
964mercial uso de um usuário individual, do site da Web. Todos os direitos reservados. Contate copyrights@aafp.org para questões85,
Volume de núdireitos
mero 10 autorais15
e/ou
desolicitaç
maio õedes de permissão. www.
2012
Multilizer PDF Translator Free version - translation is limited to ~ 3 pages per translation.
Æ
Multilizer PDF Translator Free version - translation is limited to ~ 3 pages per translation.
Exame bem masculino
TIPO: RECOMENDAÇÕES-CHAVE PARA A PRÁTICA
Provas
Recomendação clínica classificação Referências
Os
machos
adultos
devem
ser
aconselhados
sobre
hábitos
de
vida
saudáveis,
incluindo
seguinte:
o padrões de consumo podem satisfazer os
critérios de dependência do álcool e
Cessação do tabagismo A 17 aumentar o risco de morbidade associada e
Limitar a ingestão de álcool B 7 mortal-dade de doença e acidentes. 7 A
Reduzindo o risco de infecçeõ s sexualmente transmissíveis C 13-15 gaiola
ques-tionnaire (sentindo a necessidade de
Triagem para vírus do immunodeciency humano em A 15
homens risco aumentado
cortar, irritado pela crítica, culpado sobre
Dislipidemia, triagem em homens 35 anos e mais velha, A 23
beber e a necessidade de uma r" evelaço
ã " de
e em homens mais jovens com fatores de risco cardiovascular manhã) é o mais popular teste de triagem
Começando em 50 anos de rastreio de cancro colo-rectal A 42 para detecçoã de abuso de lá cool ou
de idade e continuando até pelo menos 75 anos de idade dependência nos18 cuidados primários.
Imunizações e intervalo-idade, C 64 Para os homens, bebendo arriscado
é dened como mais de 14 doses por
incluindo um toxoide tetânico, difteria reduzida
tetânico e impulsionador de pertussis acelular semana, ou mais de quatro drinques 7por
(dTpa), independentemente do tempo desde o reforço anterior ocasião.
INFECÇÕES SEXUALMENTE TRANSMISSÍVEIS
A = provas centradas no doente consistente, de boa qualidade; B = inconsistente ou
limitada-qualidade provas centradas no doente; C = consenso, evidência de doença,
Fatores de risco para DSTs (por exemplo, vários
ã de provassexo
habitual prac-tice, peritagem ou série de casos. Para obter informaçeõ s sobre a classificaço parte-ners,
tipo sys-tem, relaço
ã desprotegida, homens
vá para http://www.aafp.org/afpsort.xml.
que fazem sexo com homens) deve ser
determinadas para selecionar candidatos
adequados
13-15
Empara tela-ing.
homens de risco aumentado, alta-
uso, fatores de risco para doenças sexualmente transmissíveis (DSTs),intensidade de aconselhamento comportamental para prevenir DST
e hábitos de dieta e exercício atuais (Tabela 22,7-17 ). demonstrou para ser eficaz se realizada em vários grupo
ses-Sion mais de três a nove horas; n ú ica sessões
USO DE SUBSTÂNCIAS duram menos de 30 minutos foram encontradas 19 para ser
Homens devem ser perguntados sobre tabaco e álcool ineficaz. Triagem
para o immunodeciency humano infecço ã de vírus
usam em cada visita; evidência é insufcient para deve ser realizada rotineiramente em pessoas que relatam
recomendar triagem para uso de7,10,17 drogas
O ilí"5c-A"
itas.comportar - sem fatores de risco individuais, mas são vistas em
ioral quadro de aconselhamento é recomendado para se envolver ambientes clínicos de alto risco ou alta prevalência (por
pacientes em discussões sobre cessação do tabagismo: exemplo, clínicas STI, estabelecimentos prisionais,
(1) perguntar sobre o uso do tabaco; (2) aconselhar o abrigos, clínicas de tuberculose, clínicas de saúde para
paciente a sair através de mensagens claras e adolescentes com uma elevada15prevalência de ist, clínicas
personalizadas; (3) avaliar a vontade do paciente para que servem os homens que têm sexo com homens). Um
eresumo
recomendaç eõ s do CDC para rastreio de STI está
encerrar; (4) ajudar o paciente a desistir; e (5) organizar o disponível do USPSTF
17 em
acompanhamento
uso indevido podeeidentificar
apoio. Triagem para o
com precisã álcool
os homens cujo http://www.aafp.org/afp/2008/0315/p819.html.
montante e
DEPRESSÃO
Álcool oferecem
Tela
e aconselhamento
comportamental
intervençpara
õereduzir
s abuso
o álde
cool
(B). Inquirir sobre o consumo de álcool para identificar os
uso indevido 7 homens que consomem mais de 14 doses por semana ou
mais de quatro drinques por ocasião; Recomendamos não
mais do que dois drinques por ocasião.
Dieta saudável Fornecer intensiva dietéticas comportamental para aconselhamentoO departamento U.S. de saúde e serviços humanos
adultos com hiperlipidemia e outros fatores de risco para recomenda-se que adultos diminuem sua ingestão diária
doenças crônicas cardiovasculares e relacionados com a dieta 2(não avaliado).
de gordura saturada, colesterol, sódio e açúcar adicionado.
9
Física A AAFP reconhece que a atividade física é desejável, mas a O departamento U.S. de saúde e serviços humanos
atividade eficácia do aconselhamento médico e aconselhamento é incerta. recomenda-se que os homens participem em pelo menos
2 150 minutos de exercício aeróbio de intensidade moderada
por semana, bem como pelo menos duas vezes por 12 semana de fortalecimento
Sexualmente Tela e fornecer alta intensidade comportamentais O Centers for Disease Control and Prevention
transmitidos aconselhamento para homens com alto risco de recomenda a todos os homens de rastreio de 64 anos
infecções sexualmente transmissíveis infecções (B), sífilis (A) e infecção pelo vírus doe immunodeciency
mais jovens humano
para a (A).
infecção de vírus do
13-15 immunodeciency humano pelo 16 menos uma vez, independentemente de fator
Evidência é insufcient para avaliar o equilíbrio de vantagens
e prejudica de aconselhamento comportamental para
evitar sexualmente transmissíveis em adultos que não estão no risco aumentado (I).
13
AAFP = academia americana de médicos de família; USPSTF = força de tarefa de serviços preventivos dos Estados Unidos.
* Provas classificações: A = a USPSTF recomenda o serviço; Há alta certeza que beneficiar o líquido é substancial. B = a USPSTF recomenda o
serviço; Há alta segurança que não beneficiar o líquido é moderada ou moderada certeza que beneficiar o líquido é moderada a substancial.
C = a USPSTF recomenda contra rotineiramente prestação do serviço; pode haver considerações que suportam a prestação do serviço em um
paciente individual; Há pelo menos moderada certeza que beneficiar o líquido é pequena. D = a USPSTF recomenda contra o serviço; há certeza
moderada ou alta, que o serviço não tem nenhum líquido beneficiar ou que os danos superam os benefícios. Eu = o USPSTF conclui que a
evidência atual é insufcient para avaliar o equilíbrio de benefícios e prejuízos do serviço; evidência é inexistente, de má qualidade, ou conicting, e o equilíbrio entre benefícios e danos n
90 mm Hg ou mais. Deve ser diagnosticada somente em homens de 20 anos e mais velhos que não foram
depois de dois ou mais elevadas leituras são obtidas pelo diagnosticados com doença cardiovascular ou diabetes.
menos dois vis - seu sobre um período de uma25 a várias
semanas.
afirma que,Oem pacientes com hipertensão, o risco global de RASTREIO DE IMC
USPSTF
doença cardiovascular (tabagismo, diabetes melli-tus, dislipidemia,
Medições de peso e altura devem ser obtidas em cada
idade, sexo, vida sedentária e obesidade) deve ser considerado visita.
na Os mé
11 dicos também podem considerar a
Dyslipidemia Screen men 35 years and older (A), and men 20 to The National Cholesterol Education Program–
34 years of age who have cardiovascular risk factors (B).23 Adult Treatment Panel III recommends
screening with a fasting lipoprotein profile
24 once every five years.
Hypertension Screen men 18 years and older; evidence is lacking on The Seventh Report of the Joint National
optimal20 screening interval (A). Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood
Pressure recommends screening every two
years in patients with a blood pressure less than
120/80 mm Hg, and every year in those with a
blood pressure of 120/80 to 139/89 mm25Hg.
Obesity (body mass Screen all men and offer intensive counseling and behavioral NA
index greater than interventions to promote sustained weight11loss (A).
30 kg per m2) Evidence is insufficient to recommend for or against counseling
with behavioral interventions to promote sustained weight loss
in men with body mass index of 25 to 30 kg per m2 (I).11
Osteoporosis Evidence is insufficient to assess the balance of benefits The National Osteoporosis Foundation
and harms of screening (I); men most likely to benefit recommends performing bone mineral
from screening would have 10-year risks for osteoporotic density testing in all men 70 years and older,
fracture equal to or greater than those of 65-year-old white and in men 50 to 69 years of age who have
women who have no additional risk factors. 27 additional risk factors.26
Type 2 diabetes Screen men with a sustained blood pressure greater than The American Diabetes Association recommends
mellitus 135/80 mm Hg (B). 28 screening all men 45 years and older, or older
Evidence is insufficient to assess the balance of benefits and asymptomatic men with a body mass index
harms of screening in asymptomatic men with a blood greater than 25 kg per m2 and cardiovascular
pressure less than 135/80 mm Hg (I). 28 risk factors.29
AAFP = American Academy of Family Physicians; NA = not available; USPSTF = U.S. Preventive Services Task Force.
*—Evidence ratings: A = the USPSTF recommends the service; there is high certainty that the net benefit is substantial. B = the USPSTF recommends
the service; there is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial. C =
the USPSTF recommends against routinely providing the service; there may be considerations that support providing the service in an individual
patient; there is at least moderate certainty that the net benefit is small. D = the USPSTF recommends against the service; there is moderate or high
certainty that the service has no net benefit or that the harms outweigh the benefits. I = the USPSTF concludes that the current evidence is insufficient to assess the ba
BMIs of 25 to 34.9 kg per m . 30 In men with BMIs of 2 cardiovascular risk equivalent because it confers an ele-
35 kg per m or greater, waist circumference has limited 2 vated 10-year risk.28 The American Diabetes Association
additional predictive power of cardiovascular disease risk defines diabetes as an A1C level of at least 6.5 percent; a
beyond that of BMI alone. In Asian
30 and black men, fasting plasma glucose level of at least 126 mg per dL
waist circumference may be a better indicator of cardio- (6.99 mmol per L); a plasma glucose level of at least 200
vascular risk than BMI. 31 mg per dL (11.10 mmol per L) two hours after ingesting a
75-g glucose load; symptoms of uncontrolled hypergly-
Screening for Chronic Diseases cemia (e.g., polyuria, polydipsia, polyphagia); and a ran-
DIABETES dom plasma glucose level of at least 200 mg per dL. 29The
Thirteen million U.S. men 20 years and older (nearly USPSTF recommends screening for diabetes in men with a
one in eight) have diabetes. Diabetes
32 is considered a sustained blood pressure of at least 135/80 mm Hg.
May 15, 2012 ◆ Volume 85, Number 10 www.aafp.org/afp American Family Physician 967
Well Male Examination
968 American Family Physician www.aafp.org/afp Volume 85, Number 10 ◆ May 15, 2012
Well Male Examination
Table 4. Cancer Screening Guidelines for Men
Colorectal Begin screening at 50 years of age in men The American College of Gastroenterology endorses colonoscopy as the
of average risk, and continue until 75 years preferredscreeningtest,anddoesnotrecommenddouble-contrastbariumenema.
of age; offer fecal occult blood testing every 43
year, flexible sigmoidoscopy every five years Recommendations from the American Cancer Society are the same as
combined with fecal occult blood testing those of the USPSTF and AAFP, but include the options of computed
every three years, or colonoscopy every 10 years (A).
tomographic colonography every five years, fecal immunochemical testing every year, or
42 44
Prostate PSA-based screening should not be The American Urological Association recommends offering PSA testing and
performed at any age because the digital rectal examination to well-informed men beginning at 40 years of age and continui
harms outweigh the benefits (D; draft recommendation). 46
45
The American Cancer Society recommends discussing the risks and benefits of
Men older than 75 years should not be screening with men 50 to 75 years of age, and initiating screening at 45 years
screened because the harms outweigh of age in black men and in those with a first-degree relative who was diagnosed with pros
the benefits (D).45 47
AAFP = American Academy of Family Physicians; NA = not available; PSA = prostate-specific antigen; USPSTF = U.S. Preventive Services Task Force.
*—Evidence ratings: A = the USPSTF recommends the service; there is high certainty that the net benefit is substantial. B = the USPSTF recommends the service;
there is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial. C = the USPSTF recommends
against routinely providing the service; there may be considerations that support providing the service in an individual patient; there is at least moderate certainty
that the net benefit is small. D = the USPSTF recommends against the service; there is moderate or high certainty that the service has no net benefit or that the
harms outweigh the benefits. I = the USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service; evidence
is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined. Information from references 41 through 49.
COLORECTAL CANCER but did not reduce all-cause mortality. Fecal immuno-60
Colonoscopy is increasingly becoming the preferred chemical testing and guaiac-based FOBT have similar
screening test for colorectal cancer, but there are no sensitivity (82 percent versus 62 percent, respectively),
randomized controlled trials comparing colonoscopy, but both modalities have poor sensitivity in the detec-
flexible sigmoidoscopy, and fecal occult blood testing tion of adenomas (30 percent versus 41 percent, respec-
(FOBT) with a definable outcome of cancer-specific or tively).61Fecal DNA testing yields more false-positive
all-cause mortality. 42,55,56 No randomized trial has com- results compared with FOBT (16 percent versus 5 per-
pared colonoscopy with other screening modalities or cent).62Computed tomographic colonography has an
no screening, and observational studies suggest that the 88 percent specificity in classifying results as negative, but
incremental benefits of colonoscopy compared with otherit does not detect one out of 25 advanced lesions. 63 The
modalities may be exaggerated, given the increased harmsUSPSTF recommends beginning screening for colorec- tal
associated with the procedure and sedation. 57,58
A cancer at 50 years of age and continuing until at least 75
study evaluating colorectal cancer detection rates esti- years of age, using high-sensitivity FOBT every year,
mated that if 10,000 persons were screened, sigmoidos- flexible sigmoidoscopy every five years combined with
copy would detect 168 with advanced neoplasms versus FOBT every three years, or colonoscopy every 10 years.42
191 using colonoscopy.59
A meta-analysis revealed that FOBT offered a 13 per- Immunizations
cent relative reduction in colorectal cancer mortality Current immunization guidelines from the CDC’s
with a number needed to screen of 833 over 12 years, Advisory Committee on Immunization Practices are
May 15, 2012 ◆ Volume 85, Number 10 www.aafp.org/afp American Family Physician 969
Well Male Examination
available online (http://www.cdc.gov/mmwr/preview/ 8. U.S. Preventive Services Task Force. Screening for depression in adults.
http://www.uspreventiveservicestaskforce.org/uspstf/uspsaddepr.htm.
mmwrhtml/mm6104a9.htm). Annual influenza vac- cination is May 15, 2011.
Accessed
strongly encouraged for all adults. For men younger than 65
9. U.S. Department of Agriculture, U.S. Department of Health and
years, tetanus toxoid, reduced diphthe- ria toxoid, and Human Services. Dietary guidelines for Americans, 2010.
acellular pertussis (Tdap) vaccination is recommended, http://www.cnpp.
usda.gov/publications/DietaryGuidelines/2010/PolicyDoc/PolicyDoc. pdf. Accessed Octob
regardless of the time since the previous booster. Tdap is
also recommended over tetanus and 10. U.S. Preventive Services Task Force. Screening for illicit drug use.
64
http://www.uspreventiveservicestaskforce.org/uspstf/uspsdrug.htm. Accessed May
diphtheria toxoids (Td) vaccination for adults 65 years 21, 2011.
and older who will be in contact with children younger 11. U.S. Preventive Services Task Force. Screening for obesity in adults.
http://www.uspreventiveservicestaskforce.org/uspstf/uspsobes.htm. Accessed May
than one year. 14, 2011.
12. U.S. Department of Health and Human Services. 2008 Physical activ-
Data Sources: We reviewed the U.S. Preventive Services Task Force, ity guidelines for Americans. http://www.health.gov/paguidelines.
Cochrane, Agency for Healthcare Research and Quality, DynaMed, Essen- Accessed October 28, 2011.
tial Evidence Plus, and National Guideline Clearinghouse databases.
13. U.S. Preventive Services Task Force. Behavioral counseling to prevent sex-
A Medline search was conducted using the key words men’s health, guidelines,
ually transmitted infections. http://www.uspreventiveservicestaskforce.
sexually transmitted infections, hypertension, blood pressure screening, abdominal
org/uspstf/uspsstds.htm. Accessed May 21, 2011.
aortic aneurysm, diabetes mellitus, dyslipidemia, obesity, osteoporosis, chronic
14. U.S. Preventive Services Task Force. Screening for syphilis infection.
obstructive pulmonary disease, prostate cancer, colorectal cancer, testicular http://www.uspreventiveservicestaskforce.org/uspstf/uspssyph.htm.
cancer, Accessed May
skin cancer, and immuniza- tions. Search dates: April, May, and October 2011. 21, 2011.
15. U.S. Preventive Services Task Force. Screening for HIV. http://www.
uspreventiveservicestaskforce.org/uspstf/uspshivi.htm. Accessed May
21, 2011.
The Authors
16. Branson BM, Handsfield HH, Lampe MA, et al.; Centers for Disease
JOEL J. HEIDELBAUGH, MD, FAAFP, FACG, is a clinical associate professor Control and Prevention. Revised recommendations for HIV testing of
of family medicine and urology, and is the clerkship director in the adults, adolescents, and pregnant women in health-care settings.
MMWR
Depart- ment of Family Medicine at the University of Michigan Medical School, Ann Recomm Rep. 2006;55(RR-14):1-17.
Arbor.
17. U.S. Preventive Services Task Force. Counseling and interventions to
prevent tobacco use and tobacco-caused disease in adults and preg-
MICHELLE
TORTORELLO,
MD,
third-year
ais family
medicine
resident
the
University
at of
Michigan
Medical
School. nant women. http://www.uspreventiveservicestaskforce.org/uspstf/
uspstbac2.htm. Accessed May 21, 2011.
Address correspondence to Joel J. Heidelbaugh, MD, FAAFP, FACG, 18. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA.
1984;252(14):1905-1907.
Ypsilanti Health Center, 200 Arnet, Ste. 200, Ypsilanti, MI 48198 (e-mail: jheidel@umich.edu). Reprints are not available from the authors.
19. Lin JS, Whitlock E, O’Connor E, Bauer V. Behavioral counseling to prevent
sexually transmitted infections: a systematic review for the U.S. Preventive
Author disclosure: No relevant financial affiliations to disclose. Services Task Force. Ann Intern Med. 2008;149(7):497-508, W96-W99.
20. U.S. Preventive Services Task Force. Screening for high blood pressure.
Reaffirmation recommendation statement. http://www.uspreventive
REFERENCES servicestaskforce.org/uspstf07/hbp/hbprs.htm. Accessed May 7, 2011. 21. U.S.
Preventive Services Task Force. Screening for abdominal aor- tic aneurysm.
1. U.S. Preventive Services Task Force. USPSTF A-Z topic guide. http://
http://www.uspreventiveservicestaskforce.org/uspstf/ uspsaneu.htm. Accessed
www.uspreventiveservicestaskforce.org/uspstopics.htm. Accessed
May 15, 2011.
April 2, 2011.
2. American Academy of Family Physicians. Clinical preventive services. 22. U.S. Preventive Services Task Force. Screening for chronic obstruc-
http://www.aafp.org/online/en/home/clinical/exam.html. Accessed April tive pulmonary disease using spirometry. http://www.uspreventive
2, 2011. servicestaskforce.org/uspstf/uspscopd.htm. Accessed October 11, 2011.
23. U.S. Preventive Services Task Force. Screening for lipid disorders in
3. White AK. Report on the scoping study on men’s health. London, UK:
adults. http://www.uspreventiveservicestaskforce.org/uspstf/uspschol.
Department of Health; 2001.
htm. Accessed May 25, 2011.
4. Hsiao CJ, Cherry DK, Beatty PC, Rechtsteiner EA. National ambulatory
medical care survey: 2007 summary. http://www.cdc.gov/nchs/data/ 24. National Cholesterol Education Program. Detection, evaluation, and
nhsr/nhsr027.pdf. Accessed May 1, 2011. treatment of high blood cholesterol in adults (Adult Treatment Panel III).
Executive summary. NIH Publication No. 01-3670. http://www.nhlbi.nih.
5. Sandman D, Simantov E, An C. Out of touch: American men and the
gov/guidelines/cholesterol/atp3xsum.pdf. Accessed February 9, 2012. 25.
health care system. Commonwealth Fund Men’s and Women’s Health
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint
Survey findings. http://www.usrf.org/breakingnews/Men_out_of_
National Committee on Prevention, Detection, Evaluation, and Treat-
touch.pdf. Accessed April 13, 2011.
6. Centers for Disease Control and Prevention. FastStats: men’s health. ment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
http://www.cdc.gov/nchs/fastats/mens_health.htm. Accessed April 22, 2011. 26. National Osteoporosis Foundation. Clinician’s guide to prevention and
treatment of osteoporosis. http://www.nof.org/sites/default/files/pdfs/
7. U.S. Preventive Services Task Force. Screening and behavioral counsel- NOF_ClinicianGuide2009_v7.pdf. Accessed March 23, 2012.
ing interventions in primary care to reduce alcohol misuse. http://www. 27. U.S. Preventive Services Task Force. Screening for osteoporosis. http://
uspreventiveservicestaskforce.org/3rduspstf/alcohol/alcomisrs.htm. www.uspreventiveservicestaskforce.org/uspstf/uspsoste.htm. Accessed May
Accessed May 21, 2011. 8, 2011.
970 American Family Physician www.aafp.org/afp Volume 85, Number 10 ◆ May 15, 2012
Well Male Examination
28. U.S. Preventive Services Task Force. Screening for type 2 diabetes mel- 47. American Cancer Society. Prostate cancer: early detection. http://
litus in adults. http://www.uspreventiveservicestaskforce.org/uspstf/ www.cancer.org/Cancer/ProstateCancer/MoreInformation/
uspsdiab.htm. Accessed May 25, 2011.ProstateCancerEarlyDetection/prostate-cancer-early-detection-acs-
29. American Diabetes Association. Standards of medical care in dia- recommendations. Accessed February 9, 2012.
betes—2010 [published correction appears in Diabetes Care. 2010; 48. U.S. Preventive Services Task Force. Screening for
33(3):692]. Diabetes Care. 2010;33(suppl 1):S11-S61. http:// www.uspreventiveservicestaskforce.org/uspstf/uspsskca.htm. Accessed
30. National Heart Lung and Blood Institute. Guidelines on overweight and 2011.
obesity: electronic textbook. http://www.nhlbi.nih.gov/guidelines/
49. National Cancer Institute. Testicular cancer screening PDQ. http://www.
obesity/e_txtbk/txgd/4142.htm. Accessed May 7, 2011.
cancer.gov/cancertopics/pdq/screening/testicular/HealthProfessional. Accessed
31. Gallagher D, Visser M, Sepúlveda D, Pierson RN, Harris T, Heymsfield SB. October 22, 2011.
How useful is body mass index for comparison of body fatness across 50. National Cancer Institute. SEER cancer statistics review, 1975-2005.
age, sex, and ethnic groups? Am J Epidemiol. 1996;143(3):228-239. http://seer.cancer.gov/csr/1975_2005. Accessed February 9, 2012.
32. National Diabetes Information Clearinghouse. National diabe- 51. Schröder FH, Hugosson J, Roobol MJ, et al.; ERSPC Investigators. Screen-
tes statistics, 2011. http://www.diabetes.niddk.nih.gov/dm/pubs/ ing and prostate-cancer mortality in a randomized European study.
statistics/#fast. Accessed May 25, 2011. N Engl J Med. 2009;360(13):1320-1328.
33. Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. 52. Lin K, Lipsitz R, Miller T, Janakiraman S. Benefits and harms of pros-
Cochrane Database Syst Rev. 2007;(2):CD002945. tate-specific antigen screening for prostate cancer: an evidence
34. Lederle FA, Johnson GR, Wilson SE, et al.; Aneurysm Detection and Man- update for the U.S. Preventive Services Task Force. Ann Intern Med.
agement Veterans Affairs Cooperative Study Investigators. The Aneu- 2008;149(3):192-199.
rysm Detection and Management Study screening program: validation 53. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.
cohort and final results. Arch Intern Med. 2000;160(10):1425-1430. Systematic review: comparative effectiveness and harms of treat- ments
35. van Vlijmen-van Keulen CJ, Pals G, Rauwerda JA. Familial abdominal for clinically localized prostate cancer [published correction
aortic aneurysm: a systematic review of a genetic background. Eur J appears in Ann Intern Med. 2008;148(11):888]. Ann Intern Med.
Vasc Endovasc Surg. 2002;24(2):105-116. 2008;148(6):435-448.
36. Simon G, Nordgren D, Connelly S, Shultz PJ. Screening for abdominal 54. Richie JP, Catalona WJ, Ahmann FR, et al. Effect of patient age on
aortic aneurysms in a hypertensive patient population. Arch Intern Med. early detection of prostate cancer with serum prostate-specific antigen and
1996;156(18):2081-2084. digital rectal examination. Urology. 1993;42(4):365-374.
37. Fink HA, Lederle FA, Roth CS, Bowles CA, Nelson DB, Haas MA. The 55. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance
accuracy of physical examination to detect abdominal aortic aneurysm. for the early detection of colorectal cancer and adenomatous polyps,
Arch Intern Med. 2000;160(6):833-836. 2008: a joint guideline from the American Cancer Society, the US Multi-
Society Task Force on Colorectal Cancer, and the American College of
38. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdomi-
nal aortic aneurysms: single centre randomised controlled trial [pub- Radiology. Gastroenterology. 2008;134(5):1570-1595.
lished correction appears in BMJ. 2005;331(7521):876]. BMJ. 2005;330 56. Zapka JM, Klabunde CN, Arora NK, Yuan G, Smith JL, Kobrin SC.
(7494):750. Physi- cians’ colorectal cancer screening discussion and recommendation pat-
39. Institute of Medicine. Dietary reference intakes for calcium and vitamin terns. Cancer Epidemiol Biomarkers Prev. 2011;20(3):509-521.
D. http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for- 57. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck
Calcium-and-Vitamin-D.aspx. Accessed May 8, 2011. L. Association of colonoscopy and death from colorectal cancer. Ann
40. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for Intern Med. 2009;150(1):1-8.
chronic obstructive pulmonary disease using spirometry: summary of 58. Baxter NN, Rabeneck L. Is the effectiveness of colonoscopy “good
the evidence for the U.S. Preventive Services Task Force. Ann Intern enough” for population-based screening? J Natl Cancer Inst.
Med. 2008;148(7):535-543. 2010;102(2):70-71.
41. U.S. Preventive Services Task Force. Screening for testicular cancer. 59. Segnan N, Senore C, Andreoni B, et al.; SCORE3 Working Group-Italy.
http://www.uspreventiveservicestaskforce.org/uspstf/uspstest.htm. Comparing attendance and detection rate of colonoscopy with sig-
Accessed May 8, 2011. moidoscopy and FIT for colorectal cancer screening. Gastroenterology.
42. U.S. Preventive Services Task Force. Screening for colorectal cancer. 2007;132(7):2304-2312.
http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. 60. Moayyedi P, Achkar E. Does fecal occult blood testing really reduce
Accessed May 26, 2011. mortality? A reanalysis of systematic review data. Am J Gastroenterol.
43. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi 2006;101(2):380-384.
JM. American College of Gastroenterology guidelines for colorectal 61. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms
cancer screening 2009 [published correction appears in Am J Gastroen- with new fecal occult blood tests: update on performance characteris-
terol. 2009;104(6):1613]. Am J Gastroenterol. 2009;104(3):739-750. tics. J Natl Cancer Inst. 2007;99(19):1462-1470.
44. American Cancer Society. American Cancer Society guidelines for the 62. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood
early detection of cancer. http://www.cancer.org/Healthy/FindCancer testing for screen detection of colorectal neoplasia. Ann Intern Med.
Early/CancerScreeningGuidelines/american-cancer-society-guidelines- 2008;149(7):441-450, W81.
for-the-early-detection-of-cancer. Accessed October 22, 2011. 63. Regge D, Laudi C, Galatola G, et al. Diagnostic accuracy of com-
45. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a puted tomographic colonography for the detection of advanced
review of the evidence for the U.S. Preventive Services Task Force. Ann neoplasia in individuals at increased risk of colorectal cancer. JAMA.
Intern Med. 2011;155(11):762-771. 2009;301(23):2453-2461.
46. American Urological Association. Prostate-specific antigen best prac- 64. Centers for Disease Control and Prevention (CDC). Recommended adult
tice statement: 2009 update. http://www.auanet.org/content/media/ immunization schedule—United States, 2011. MMWR Morb Mortal
psa09.pdf. Accessed May 14, 2011. Wkly Rep. 2011;60(4):1-4.
May 15, 2012 ◆ Volume 85, Number 10 www.aafp.org/afp American Family Physician 971